Emily S. Lebow

Emily S. Lebow

Auto-generated profile, based on publicly available information

Emily S. Lebow

Department of Radiation Oncology University of Pennsylvania Philadelphia Pennsylvania USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
ESEmily Schapira
Emily Schapira
HHHarper Hubbeling
Harper Hubbeling
BYBeow Y. Yeap
Beow Y. Yeap
WMWilliam A. Mehan
William A. Mehan
ASAlice T. Shaw
Alice T. Shaw
HSHelen A. Shih
Helen A. Shih

1 April 2018 in Journal of Thoracic Oncology
Verified
Journal Article
Closed access
HHHarper G. Hubbeling
Harper G. Hubbeling
ESEmily F. Schapira
Emily F. Schapira
NHNora K. Horick
Nora K. Horick
KGKelly E.H. Goodwin
Kelly E.H. Goodwin
JLJessica J. Lin
Jessica J. Lin
JGJustin F. Gainor
Justin F. Gainor

1 February 2018 in JAMA Oncology
Verified
Journal Article
Open access
PDF file
WHWilliam L. Hwang
William L. Hwang
ANAndrzej Niemierko
Andrzej Niemierko
KLKatie N. Lee
Katie N. Lee
HHHarper Hubbeling
Harper Hubbeling
ESEmily Schapira
Emily Schapira
FKFlorence K. Keane
Florence K. Keane
This cohort study evaluates the clinical outcomes in patients with metastatic lung cancer treated with PD-1/PD-L1 inhibitors and thoracic radiotherapy.

1 October 2014 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
PDF file
CYCatherine J. Yang
Catherine J. Yang
LBLindsay A. Bliss
Lindsay A. Bliss
ESEmily F. Schapira
Emily F. Schapira
SFSteven D. Freedman
Steven D. Freedman
SNSing Chau Ng
Sing Chau Ng
JTJennifer F. Tseng
Jennifer F. Tseng

1 September 2015 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
PDF file
CMChristine L. Monteleon
Christine L. Monteleon
AMAndrew McNeal
Andrew McNeal
EDElizabeth K. Duperret
Elizabeth K. Duperret
SOSeung J. Oh
Seung J. Oh
ESEmily Schapira
Emily Schapira
TRTodd W. Ridky
Todd W. Ridky
IQ motif–containing GTPase-activating protein (IQGAP) scaffolding proteins regulate many essential cellular processes including growth factor receptor signaling, cytoskeletal rearrangement, adhesion, and proliferation and are highly expressed in many cancers. Using genetically engineered human skin tissue in vivo, we demonstrate that diminished, sub-physiologic expression of IQGAP1 or IQGAP3 is sufficient to maintain normal epidermal homeostasis, whereas significantly higher levels are required to support tumorigenesis. To target this tumor-specific IQGAP requirement in vivo, we engineered epidermal keratinocytes to express individual IQGAP protein domains designed to compete with endogenous IQGAPs for effector protein binding. Expression of the IQGAP1-IQ motif decoy domain in epidermal tissue in vivo inhibits oncogenic Ras-driven mitogen-activated protein kinase signaling and antagonizes tumorigenesis, without disrupting normal epidermal proliferation or differentiation. These findings define essential non-redundant roles for IQGAP1 and IQGAP3 in the epidermis and demonstrate the potential of IQGAP antagonism for cancer therapy.

1 January 2019 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
ADAlmut Dutz
Almut Dutz
ALArmin Lühr
Armin Lühr
LALinda Agolli
Linda Agolli
ETEsther G.C. Troost
Esther G.C. Troost
MKMechthild Krause
Mechthild Krause
SLSteffen Löck
Steffen Löck